Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Miltefosine: a new remedy for leishmaniasis].
Dorlo TP, Eggelte TA, Beijnen JH, de Vries PJ. Dorlo TP, et al. Ned Tijdschr Geneeskd. 2006 Dec 9;150(49):2697-701. Ned Tijdschr Geneeskd. 2006. PMID: 17194005 Review. Dutch.
Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients.
Dorlo TP, van Thiel PP, Huitema AD, Keizer RJ, de Vries HJ, Beijnen JH, de Vries PJ. Dorlo TP, et al. Antimicrob Agents Chemother. 2008 Aug;52(8):2855-60. doi: 10.1128/AAC.00014-08. Epub 2008 Jun 2. Antimicrob Agents Chemother. 2008. PMID: 18519729 Free PMC article. Clinical Trial.
Severe encephalopathy and polyneuropathy induced by dichloroacetate.
Brandsma D, Dorlo TP, Haanen JH, Beijnen JH, Boogerd W. Brandsma D, et al. Among authors: dorlo tp. J Neurol. 2010 Dec;257(12):2099-100. doi: 10.1007/s00415-010-5654-9. Epub 2010 Jul 15. J Neurol. 2010. PMID: 20632025 No abstract available.
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.
Omollo R, Alexander N, Edwards T, Khalil EA, Younis BM, Abuzaid AA, Wasunna M, Njoroge N, Kinoti D, Kirigi G, Dorlo TP, Ellis S, Balasegaram M, Musa AM. Omollo R, et al. Among authors: dorlo tp. Trials. 2011 Jun 30;12:166. doi: 10.1186/1745-6215-12-166. Trials. 2011. PMID: 21718522 Free PMC article. Clinical Trial.
Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults.
Byakika-Kibwika P, Lamorde M, Okaba-Kayom V, Mayanja-Kizza H, Katabira E, Hanpithakpong W, Pakker N, Dorlo TP, Tarning J, Lindegardh N, de Vries PJ, Back D, Khoo S, Merry C. Byakika-Kibwika P, et al. Among authors: dorlo tp. J Antimicrob Chemother. 2012 May;67(5):1217-23. doi: 10.1093/jac/dkr596. Epub 2012 Feb 8. J Antimicrob Chemother. 2012. PMID: 22316571 Free PMC article. Clinical Trial.
127 results